For five years, insulin manufacturer Novo Nordisk agrees to cap out-of-pocket cost of its insulin treatments at $35 per month, and provide free insulin to the neediest Minnesotans.
In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback